European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In
accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding
of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry.
Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and
genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings
that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and
improvement of treatments, ideally paving the way for prevention and recovery.
European Neuropsychopharmacology is the official
journal of the http://www.ecnp.euEuropean College of Neuropsychopharmacology (ECNP).
Electronic
usage:
An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery
systems for scientific, technical and medical information.
Average monthly article downloads for this journal: 29,000
https://www.uk.elsevierhealth.com/european-neuropsychopharmacology-0924977x.html103282European Neuropsychopharmacologyhttps://www.uk.elsevierhealth.com/media/catalog/product/0/9/0924977x_17.jpg00GBPInStock <P><IT>European Neuropsychopharmacology</IT> is the official publication of the European College of Neuropsychopharmacology (ECNP). In
accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding
of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry.
Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and
genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings
that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and
improvement of treatments, ideally paving the way for prevention and recovery.
<P><IT>European Neuropsychopharmacology</IT> is the official
journal of the <URL><HREF>http://www.ecnp.eu</HREF><HTXT>European College of Neuropsychopharmacology</HTXT></URL> (ECNP).
<P>Electronic
usage:<BR>
An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery
systems for scientific, technical and medical information.
<P>Average monthly article downloads for this journal: <B>29,000</B>
00103281European Neuropsychopharmacology00https://www.uk.elsevierhealth.com/media/catalog/product/https://www.uk.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockDomestic1 YearIndividual0924-977XJOURNALELSEVIERIN STOCK0924-977XVolume 29journalsJournalsNoNoNoNoPlease SelectPlease SelectPlease Select